网状Meta分析中总体证据的量化与呈现
本文针对网状Meta分析(NMA)中治疗比较证据报告不充分的问题,将治疗网络按不同假设分为三类,并提出有效研究数、有效样本量和有效精度三个新指标,以初步量化NMA获得的总体证据。通过四个案例研究演示了这些指标的推导与解释,并指出不同证据呈现方式会使治疗网络外观差异明显。
要点
- 提出有效研究数、有效样本量和有效精度三个指标量化NMA总体证据。
- 治疗网络可按研究数、样本量或精度比例呈现,不同方式外观差异明显。
- 部分比较从NMA中获益可能很小,建议报告所有比较的总体证据。
核心结论
- 所提三个指标可初步量化NMA总体证据,并提示间接证据带来的额外研究数、样本量和精度。
研究设计与样本
- 方法学文章,将治疗网络按不同假设分为三类,并用四个案例研究演示指标推导与解释。
主要发现
- 不同证据呈现方式下治疗网络外观差异明显。
- 所提指标可清晰展示所有治疗比较的总体证据。
- 部分比较从NMA中获益可能很小。
关键数值与推荐
- 三个新指标为有效研究数、有效样本量和有效精度。
- 治疗网络分为边宽与研究数、样本量或精度成比例的三类。
临床怎么用
- 研究者应呈现所有治疗比较的总体证据,以便读者初步评估NMA质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Network meta-analysis (NMA) has become an increasingly used tool to compare multiple treatments simultaneously by synthesizing direct and indirect evidence in clinical research. However, many existing studies did not properly report the evidence of treatment comparisons and show the comparison structure to audience. In addition, nearly all treatment networks presented only direct evidence, not overall evidence that can reflect the benefit of performing NMAs. This article classifies treatment networks into three types under different assumptions; they include networks with each treatment comparison's edge width proportional to the corresponding number of studies, sample size, and precision. In addition, three new measures (ie, the effective number of studies, the effective sample size, and the effective precision) are proposed to preliminarily quantify overall evidence gained in NMAs. They permit audience to intuitively evaluate the benefit of performing NMAs, compared with pairwise meta-analyses based on only direct evidence. We use four case studies, including one illustrative example, to demonstrate their derivations and interpretations. Treatment networks may look fairly differently when different measures are used to present the evidence. The proposed measures provide clear information about overall evidence of all treatment comparisons, and they also imply the additional number of studies, sample size, and precision obtained from indirect evidence. Some comparisons may benefit little from NMAs. Researchers are encouraged to present overall evidence of all treatment comparisons, so that audience can preliminarily evaluate the quality of NMAs.
引用
- Lin L. Quantifying and presenting overall evidence in network meta-analysis. Stat Med. 2018. PMID: 30019428. doi:10.1002/sim.7905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。